PP
AH

PDT Partners’s Accretive Health AH Stock Holding History

PDT Partners’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,966
Closed -$173K – 1485
2013
Q3 		$173K Sell
18,966
-14,150
-43% -$141K ﹤0.01% 1415
2013
Q2 		$358K Buy
+33,116
New +$348K 0.01% 1203

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

PDT Partners's AH Position: Q4 2013 in Review

PDT Partners sold out of Accretive Health (AH) in Q4 2013, closing a stake of 18,966 shares — an estimated $173K sold.

PDT Partners first reported a position in AH in Q2 2013 and held it in 2 quarters. The position peaked at $358K in Q2 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

  • PDT Partners reported no remaining Accretive Health position as of Q4 2013 after selling out during the quarter.
  • PDT Partners sold 18,966 Accretive Health shares in Q4 2013, an estimated $173K.
  • PDT Partners first reported a position in Accretive Health in Q2 2013 and held it in 2 quarters.
  • PDT Partners's Accretive Health position peaked at $358K in Q2 2013.
  • 85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on PDT Partners's 13F filing for Q4 2013, filed 14 Feb 2014.